Quattro Advisors’s Biodesix BDSX Stock Holding History

Quattro Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-187	Closed	-$1.27K	–	103
2025 Q4	$1.27K	Buy	+187	New	+$1.38K	﹤0.01%	418

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Quattro Advisors's BDSX Position: Q1 2026 in Review

Quattro Advisors sold out of Biodesix (BDSX) in Q1 2026, closing a stake of 187 shares — an estimated $1.27K sold.

Quattro Advisors first reported a position in BDSX in Q4 2025 and held it in 1 quarter. The position peaked at $1.27K in Q4 2025. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

Quattro Advisors reported no remaining Biodesix position as of Q1 2026 after selling out during the quarter.
Quattro Advisors sold 187 Biodesix shares in Q1 2026, an estimated $1.27K.
Quattro Advisors first reported a position in Biodesix in Q4 2025 and held it in 1 quarter.
Quattro Advisors's Biodesix position peaked at $1.27K in Q4 2025.
40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Quattro Advisors's 13F filing for Q1 2026, filed 15 May 2026.